Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Esther G C Troost
Affiliation
German Cancer Research Center (DKFZ)
ORCID
Career Start Year
2003
Papers
213
H Index
40
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
37972734
Prediction of radiation pneumonitis using the effective α/β of lungs and heart in NSCLC patients treated with proton beam therapy.
Radiother Oncol
2024
37751793
A Phase 1 Study of the DNA-PK Inhibitor Peposertib in Combination With Radiation Therapy With or Without Cisplatin in Patients With Advanced Head and Neck Tumors.
Int J Radiat Oncol Biol Phys
2024
36222474
Ultrasonic bone cement removal efficiency in total joint arthroplasty revision: A computer tomographic-based cadaver study.
J Orthop Res
2023
37835591
Multitask Learning with Convolutional Neural Networks and Vision Transformers Can Improve Outcome Prediction for Head and Neck Cancer Patients.
Cancers (Basel)
2023
37736140
Patients' needs in proton therapy: A survey among ten European facilities.
Clin Transl Radiat Oncol
2023
37568587
Normo- or Hypo-Fractionated Photon or Proton Radiotherapy in the Management of Locally Advanced Unresectable Pancreatic Cancer: A Systematic Review.
Cancers (Basel)
2023
37449022
Comparison of 3D and 4D robustly optimized proton treatment plans for non-small cell lung cancer patients with tumour motion amplitudes larger than 5Â mm.
Phys Imaging Radiat Oncol
2023
37312079
Lung cancer multi-omics digital human avatars for integrating precision medicine into clinical practice: the LANTERN study.
BMC Cancer
2023
36879464
STereotactic Arrhythmia Radioablation (STAR): the Standardized Treatment and Outcome Platform for Stereotactic Therapy Of Re-entrant tachycardia by a Multidisciplinary consortium (STOPSTORM.eu) and review of current patterns of STAR practice in Europe.
Europace
2023
36801809
Unchanged perfusion in normal-appearing white and grey matter of glioma patients nine months after proton beam irradiation.
Acta Oncol
2023
36765628
Longitudinal and Multimodal Radiomics Models for Head and Neck Cancer Outcome Prediction.
Cancers (Basel)
2023
34774653
Reduction of clinical safety margins in proton therapy enabled by the clinical implementation of dual-energy CT for direct stopping-power prediction.
Radiother Oncol
2022
35482115
Correction to: Joint EANM/SNMMI/ESTRO practice recommendations for the use of 2-[<sup>18</sup>F]FDG PET/CT external beam radiation treatment planning in lung cancer V1.0.
Eur J Nucl Med Mol Imaging
2022
35342943
Experimental validation of 4D log file-based proton dose reconstruction for interplay assessment considering amplitude-sorted 4DCTs.
Med Phys
2022
35756665
18F-Fluorodeoxyglucose Positron Emission Tomography of Head and Neck Cancer: Location and HPV Specific Parameters for Potential Treatment Individualization.
Front Oncol
2022
35565207
Local Control after Locally Ablative, Image-Guided Radiotherapy of Oligometastases Identified by Gallium-68-PSMA-Positron Emission Tomography in Castration-Sensitive Prostate Cancer Patients (OLI-P).
Cancers (Basel)
2022
35715462
Analysis of MRI and CT-based radiomics features for personalized treatment in locally advanced rectal cancer and external validation of published radiomics models.
Sci Rep
2022
35657056
Assessment of gene expressions from squamous cell carcinoma of the head and neck to predict radiochemotherapy-related xerostomia and dysphagia.
Acta Oncol
2022
35447285
Subjective memory impairment in glioma patients with curative radiotherapy.
Radiother Oncol
2022
35513132
Treatment planning comparison in the PROTECT-trial randomising proton versus photon beam therapy in oesophageal cancer: Results from eight European centres.
Radiother Oncol
2022
35965663
Time- and dose-dependent volume decreases in subcortical grey matter structures of glioma patients after radio(chemo)therapy.
Clin Transl Radiat Oncol
2022
35993091
Immunohistochemical analyses of paraffin-embedded sections after primary surgery or trimodality treatment in esophageal carcinoma.
Clin Transl Radiat Oncol
2022
36202941
Integrated radiogenomics analyses allow for subtype classification and improved outcome prognosis of patients with locally advanced HNSCC.
Sci Rep
2022
35988776
A systematic review of clinical studies on variable proton Relative Biological Effectiveness (RBE).
Radiother Oncol
2022
36230481
Orthotopic Glioblastoma Models for Evaluation of the Clinical Target Volume Concept.
Cancers (Basel)
2022
35884564
Impact of Blood Parameters and Normal Tissue Dose on Treatment Outcome in Esophageal Cancer Patients Undergoing Neoadjuvant Radiochemotherapy.
Cancers (Basel)
2022
33786695
Overestimation of grey matter atrophy in glioblastoma patients following radio(chemo)therapy.
MAGMA
2022
35093408
The European Particle Therapy Network (EPTN) consensus on the follow-up of adult patients with brain and skull base tumours treated with photon or proton irradiation.
Radiother Oncol
2022
35066001
Perspective paper about the joint EANM/SNMMI/ESTRO practice recommendations for the use of 2-[<sup>18</sup>F]FDG-PET/CT external beam radiation treatment planning in lung cancer.
Radiother Oncol
2022
35243021
Development of explanatory movies for the delineation of new organs at risk in neuro-oncology.
Clin Transl Radiat Oncol
2022
35243020
Pre-treatment visualization of predicted radiation-induced acute alopecia in brain tumour patients.
Clin Transl Radiat Oncol
2022
34902370
Current practice in proton therapy delivery in adult cancer patients across Europe.
Radiother Oncol
2022
35022844
Joint EANM/SNMMI/ESTRO practice recommendations for the use of 2-[<sup>18</sup>F]FDG PET/CT external beam radiation treatment planning in lung cancer V1.0.
Eur J Nucl Med Mol Imaging
2022
34697985
Towards online adaptive proton therapy: first report of plan-library-based plan-of-the-day approach.
Acta Oncol
2022
32638040
Evaluation of response using FDG-PET/CT and diffusion weighted MRI after radiochemotherapy of pancreatic cancer: a non-randomized, monocentric phase II clinical trial-PaCa-DD-041 (Eudra-CT 2009-011968-11).
Strahlenther Onkol
2021
33743750
Current status and developments of German curriculum-based residency training programmes in radiation oncology.
Radiat Oncol
2021
33848609
Optimal Allocation of Proton Therapy Slots in Combined Proton-Photon Radiation Therapy.
Int J Radiat Oncol Biol Phys
2021
33872640
Identification of patient benefit from proton beam therapy in brain tumour patients based on dosimetric and NTCP analyses.
Radiother Oncol
2021
33805542
MR Image Changes of Normal-Appearing Brain Tissue after Radiotherapy.
Cancers (Basel)
2021
33748441
The ROCOCO performance scoring system translates dosimetric differences into clinically relevant endpoints: Comparing IMPT to VMAT in an example pilocytic astrocytoma dataset.
Clin Transl Radiat Oncol
2021
34538585
Role of Postoperative Radiotherapy in the Management for Resected NSCLC - Decision Criteria in Clinical Routine Pre- and Post-LungART.
Clin Lung Cancer
2021
34537290
Reduced diffusion in white matter after radiotherapy with photons and protons.
Radiother Oncol
2021
34592361
The impact of anatomical changes during photon or proton based radiation treatment on tumor dose in glioblastoma dose escalation trials.
Radiother Oncol
2021
34015385
Update of the EPTN atlas for CT- and MR-based contouring in Neuro-Oncology.
Radiother Oncol
2021
34261141
Value of PET imaging for radiation therapy.
Nuklearmedizin
2021
33285270
Toxicity of L19-Interleukin 2 Combined with Stereotactic Body Radiation Therapy: A Phase 1 Study.
Int J Radiat Oncol Biol Phys
2021
33285194
Proposal for the delineation of neoadjuvant target volumes in oesophageal cancer.
Radiother Oncol
2021
33252044
Generation of biological hypotheses by functional imaging links tumor hypoxia to radiation induced tissue inflammation/glucose uptake in head and neck cancer.
Radiother Oncol
2021
33186683
Role of radiotherapy in the management of brain metastases of NSCLC - Decision criteria in clinical routine.
Radiother Oncol
2021
33207020
Technical Note: ADAM PETer - An anthropomorphic, deformable and multimodality pelvis phantom with positron emission tomography extension for radiotherapy.
Med Phys
2021
1 - 50 of 213
Column Actions
Search
Recommended Authors
Jason W Chan
University of California San Francisco
Career Start Year
2017
Number of shared co-authors
2
Erqi L Pollom
Stanford University
Career Start Year
2014
Number of shared co-authors
2
Soumyajit Roy
Rush University Medical Center
Career Start Year
2013
Number of shared co-authors
2
Musaddiq J Awan
Medical College of Wisconsin
Career Start Year
2013
Number of shared co-authors
3
Andrew Warner
Western University and London Regional Cancer Program
Career Start Year
2013
Number of shared co-authors
2
Nikhil T Sebastian
Emory University
Career Start Year
2011
Number of shared co-authors
0
Melvin L K Chua
National Cancer Centre Singapore
Career Start Year
2011
Number of shared co-authors
3
Joseph Sia
Peter MacCallum Cancer Centre, University of Melbourne
Career Start Year
2011
Number of shared co-authors
3
Hanbo Chen
University of Toronto
Career Start Year
2010
Number of shared co-authors
3
Steven H Lin
University of Texas MD Anderson Cancer Center
Career Start Year
2008
Number of shared co-authors
3
Emmanouil Fokas
Universityhospital Frankfurt
Career Start Year
2007
Number of shared co-authors
5
Daniel R Gomez
Memorial Sloan Kettering Cancer Center
Career Start Year
2005
Number of shared co-authors
3
Daniel J Ma
Mayo Clinic
Career Start Year
2005
Number of shared co-authors
3
Albert J Chang
University of California Los Angeles
Career Start Year
2003
Number of shared co-authors
1
Philip Wong
Princess Margaret Cancer Centre, University Health Network
Career Start Year
2002
Number of shared co-authors
3
Zhigang Zhang
Memorial Sloan Kettering Cancer Center
Career Start Year
2001
Number of shared co-authors
2
Clifton D Fuller
The University of Texas MD Anderson Cancer Center
Career Start Year
2001
Number of shared co-authors
11
Michelle Alonso-Basanta
Perelman School of Medicine, University of Pennsylvania
Career Start Year
2000
Number of shared co-authors
2
David A Palma
University of Western Ontario
Career Start Year
2000
Number of shared co-authors
7
Nancy Y Lee
Memorial Sloan Kettering Cancer Center
Career Start Year
1999
Number of shared co-authors
10
Steve E Braunstein
University of California san francisco
Career Start Year
1998
Number of shared co-authors
3
Anthony J Cmelak
Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
Career Start Year
1997
Number of shared co-authors
0
Puneeth Iyengar
UT Southwestern Medical Center, Center for Human Nutrition
Career Start Year
1996
Number of shared co-authors
1
Glenn Bauman
Western University and London Regional Cancer Program
Career Start Year
1994
Number of shared co-authors
1
William F Hartsell
Proton Therapy Center- Northwestern University
Career Start Year
1989
Number of shared co-authors
2
Danielle Van den Weyngaert
University of Antwerp
Career Start Year
1987
Number of shared co-authors
3
John L Humm
Memorial Sloan Kettering Cancer Center
Career Start Year
1986
Number of shared co-authors
9
Peter Hoskin
Mount Vernon Cancer Centre
Career Start Year
1985
Number of shared co-authors
6
Andrzej Niemierko
Massachusetts General Hospital
Career Start Year
1982
Number of shared co-authors
2
John P Kirkpatrick
Duke University Medical Center
Career Start Year
1978
Number of shared co-authors
3
row(s) 1 - 30 of 30
Collaborators
Johan Bussink
Radboud University, Nijmegen Medical Centre
Co-authored papers
36
Philippe Lambin
Maastricht University
Co-authored papers
32
Dirk De Ruysscher
Maastro Clinic
Co-authored papers
29
Johannes H A M Kaanders
Radboud University Medical Center
Co-authored papers
26
Wouter van Elmpt
Maastricht University Medical Center+
Co-authored papers
21
Erik Roelofs
Maastricht University Medical Centre+
Co-authored papers
12
Frank J P Hoebers
Maastricht University Medical Centre
Co-authored papers
10
Ralph T H Leijenaar
Maastricht University Medical Center (MUMC+)
Co-authored papers
9
Cary Oberije
Maastricht University Medical Centre
Co-authored papers
8
Stephanie Peeters
University of Liege, Centre Hospitalier Universitaire de Liege
Co-authored papers
7
Bianca A W Hoeben
Radboud University Medical Center
Co-authored papers
6
Ludwig Dubois
Maastricht University
Co-authored papers
6
Albert J van der Kogel
University of Wisconsin School of Medicine and Public Health
Co-authored papers
6
Ronald Boellaard
Cancer Center Amsterdam, Vrije Universiteit Amsterdam
Co-authored papers
4
Fiona Blackhall
The University of Manchester
Co-authored papers
4
Vincenzo Valentini
Universita Cattolica del Sacro Cuore
Co-authored papers
4
Andre Dekker
Maastricht University Medical Centre
Co-authored papers
4
Georgi Nalbantov
Department of Radiation Oncology (MAASTRO Clinic)
Co-authored papers
4
Heiko Sch??der
Memorial Sloan Kettering Cancer Center
Co-authored papers
3
Hugo J W L Aerts
Harvard Medical School
Co-authored papers
3
Emmanuel Rios Velazquez
Research Institute GROW, Maastricht University
Co-authored papers
2
Paul N Span
Radboud University Medical Center
Co-authored papers
2
Karin Dieckmann
Medical University of Vienna
Co-authored papers
2
Helen A Shih
Massachusetts General Hospital and Harvard Medical School
Co-authored papers
2
Mathieu Hatt
INSERM
Co-authored papers
2
Kim M Smits
Maastricht University Medical Center+
Co-authored papers
2
Natasja G Lieuwes
Maastricht University
Co-authored papers
2
Christos Davatzikos
University of Pennsylvania
Co-authored papers
1
Ghazaleh Tabatabai
University Hospital Tubingen, Eberhard-Karls-University Tubingen
Co-authored papers
1
Henning M??ller
University of Applied Sciences of Western Switzerland (HES-SO Valais)
Co-authored papers
1
1 - 30